Inventor · disambiguated record
David Paschon
Also filed as: PASCHON DAVID · PASCHON DAVID EMANUEL
49 granted patents·15 pending applications·1,316 citations·filing 2008–2023
98Inventor score
Files withSANGAMO THERAPEUTICS INC33SANGAMO BIOSCIENCES INC22DEKELVER RUSSELL2GREGORY PHILIP D2BONINI MARIA CHIARA1
Top patents by PatentIndex Score
64 records- 0198US9458205B2Modified DNA-binding proteins and uses thereofSANGAMO BIOSCIENCES INC·Filed 2012·Granted Oct 4, 2016·87 cites·25 claims
- 0298US8586526B2DNA-binding proteins and uses thereofGREGORY PHILIP D·Filed 2011·Granted Nov 19, 2013·431 cites·11 claims
- 0398US8110379B2Targeted integration into the PPP1R12C locusDEKELVER RUSSELL·Filed 2008·Granted Feb 7, 2012·188 cites·26 claims
- 0497US9567609B2Compositions for linking DNA-binding domains and cleavage domainsSANGAMO BIOSCIENCES INC·Filed 2014·Granted Feb 14, 2017·41 cites·16 claims
- 0597US8563314B2Methods and compositions for modulating PD1GREGORY PHILIP D·Filed 2010·Granted Oct 22, 2013·86 cites·41 claims
- 0696US8772453B2Compositions for linking zinc finger modulesPASCHON DAVID·Filed 2011·Granted Jul 8, 2014·98 cites·15 claims
- 0795US8956828B2Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleasesBONINI MARIA CHIARA·Filed 2010·Granted Feb 17, 2015·203 cites·15 claims
- 0894US9937207B2Targeted disruption of T cell receptor genes using talensSANGAMO BIOSCIENCES INC·Filed 2014·Granted Apr 10, 2018·37 cites·13 claims
- 0994US9222105B2Methods and compositions for modification of the HPRT locusSANGAMO BIOSCIENCES INC·Filed 2012·Granted Dec 29, 2015·16 cites·29 claims
- 1094US8912138B2DNA-binding proteins and uses thereofSANGAMO BIOSCIENCES INC·Filed 2013·Granted Dec 16, 2014·14 cites·13 claims
- 1193US10046028B2Methods and compositions for modulating PD1SANGAMO BIOSCIENCES INC·Filed 2016·Granted Aug 14, 2018·7 cites·3 claims
- 1292US8895264B2Methods and compositions for modification of the HPRT locusSANGAMO BIOSCIENCES INC·Filed 2012·Granted Nov 25, 2014·10 cites·17 claims
- 1391US10253333B2DNA-binding proteins and uses thereofSANGAMO THERAPEUTICS INC·Filed 2017·Granted Apr 9, 2019·5 cites·12 claims
- 1491US9163245B2Compositions for linking zinc finger modulesSANGAMO BIOSCIENCES INC·Filed 2014·Granted Oct 20, 2015·13 cites·11 claims
- 1590US10500229B2Targeted disruption of the MHC cell receptorSANGAMO THERAPEUTICS INC·Filed 2016·Granted Dec 10, 2019·6 cites·8 claims
- 1690US9771403B2Methods and compositions for treating hemophiliaSANGAMO BIOSCIENCES INC·Filed 2014·Granted Sep 26, 2017·8 cites·26 claims
- 1789US10435441B2HTT repressors and uses thereofSANGAMO BIOSCIENCES INC·Filed 2016·Granted Oct 8, 2019·4 cites·7 claims
- 1889US10407476B2Methods and compositions for treating hemophiliaSANGAMO THERAPEUTICS INC·Filed 2017·Granted Sep 10, 2019·4 cites·11 claims
- 1989US10081661B2Methods and compositions for genome engineeringSANGAMO BIOSCIENCES INC·Filed 2014·Granted Sep 25, 2018·9 cites·14 claims
- 2088US10968261B2Methods and compositions for genome engineeringSANGAMO THERAPEUTICS INC·Filed 2018·Granted Apr 6, 2021·2 cites·12 claims
- 2188US9322005B2DNA-binding proteins and uses thereofSANGAMO BIOSCIENCES INC·Filed 2013·Granted Apr 26, 2016·6 cites·22 claims
- 2286US11661612B2DNA-binding proteins and uses thereofSANGAMO THERAPEUTICS INC·Filed 2019·Granted May 30, 2023·1 cites·12 claims
- 2385US11123443B2Htt repressors and uses thereofSANGAMO THERAPEUTICS INC·Filed 2019·Granted Sep 21, 2021·2 cites·9 claims
- 2485US10960085B2Modulation of liver genesSANGAMO THERAPEUTICS INC·Filed 2017·Granted Mar 30, 2021·3 cites·19 claims
- 2585US10724020B2Compositions for linking DNA-binding domains and cleavage domainsSANGAMO BIOSCIENCES INC·Filed 2016·Granted Jul 28, 2020·2 cites·12 claims
- 2685US9493750B2DNA-binding proteins and uses thereofSANGAMO BIOSCIENCES INC·Filed 2013·Granted Nov 15, 2016·4 cites·10 claims
- 2784US10155011B2Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleasesSANGAMO BIOSCIENCES INC·Filed 2015·Granted Dec 18, 2018·4 cites·13 claims
- 2884US9783827B2DNA-binding proteins and uses thereofSANGAMO BIOSCIENCES INC·Filed 2016·Granted Oct 10, 2017·2 cites·12 claims
- 2983US9650648B2Methods and compositions for treatment of a genetic conditionSANGAMO BIOSCIENCES INC·Filed 2013·Granted May 16, 2017·4 cites·11 claims
- 3083US9267154B2Targeted integration into the PPP1R12C locusSANGAMO BIOSCIENCES INC·Filed 2014·Granted Feb 23, 2016·2 cites·19 claims
- 3182US11235026B2Methods and compositions for modulating PD1SANGAMO THERAPEUTICS INC·Filed 2018·Granted Feb 1, 2022·1 cites·7 claims
- 3281US9161995B2Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (CFTR) geneGUSCHIN DMITRY M·Filed 2012·Granted Oct 20, 2015·8 cites·19 claims
- 3381US2023416775A1Methods and compositions for treatment of a genetic conditionSANGAMO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3480US9963715B2Methods and compositions for treatment of a genetic conditionSANGAMO BIOSCIENCES INC·Filed 2013·Granted May 8, 2018·3 cites·11 claims
- 3579US10918668B2Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleasesSANGAMO THERAPEUTICS INC·Filed 2018·Granted Feb 16, 2021·1 cites·9 claims
- 3679US9402879B2Methods and compositions for modulating PD1SANGAMO BIOSCIENCES INC·Filed 2013·Granted Aug 2, 2016·2 cites·7 claims
- 3779US2022356493A1Dna-binding proteins and uses thereofSANGAMO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3877US8822221B2Targeted integration into the PPP1R12C locusDEKELVER RUSSELL·Filed 2011·Granted Sep 2, 2014·1 cites·18 claims
- 3977US2023346844A1Targeted disruption of t cell receptor genes using engineered zinc finger protein nucleasesSANGAMO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4076US2021188926A1Methods and compositions for genome engineeringSANGAMO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4175US12043650B2Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) geneSANGAMO THERAPEUTICS INC·Filed 2023·Granted Jul 23, 2024·0 cites·17 claims
- 4275US11285175B2Targeted disruption of the MHC cell receptorSANGAMO THERAPEUTICS INC·Filed 2019·Granted Mar 29, 2022·0 cites·13 claims
- 4375US10538787B2Compositions for linking DNA-binding domains and cleavage domainsSANGAMO THERAPEUTICS INC·Filed 2017·Granted Jan 21, 2020·1 cites·16 claims
- 4474US2022175839A1Targeted disruption of the mhc cell receptorSANGAMO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4572US11634463B2Methods and compositions for treating hemophiliaSANGAMO THERAPEUTICS INC·Filed 2019·Granted Apr 25, 2023·0 cites·11 claims
- 4672US11041174B2Compositions for linking DNA-binding domains and cleavage domainsSANGAMO THERAPEUTICS INC·Filed 2019·Granted Jun 22, 2021·0 cites·17 claims
- 4770US11439666B2Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleasesSANGAMO THERAPEUTICS INC·Filed 2018·Granted Sep 13, 2022·0 cites·12 claims
- 4868US11492643B2Methods and compositions for treatment of a genetic conditionSANGAMO THERAPEUTICS INC·Filed 2018·Granted Nov 8, 2022·0 cites·6 claims
- 4967US2022315932A1Targeted disruption of the t cell receptorSANGAMO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 5066US11649468B2Targeted integration into the PPP1R12C locusSANGAMO THERAPEUTICS INC·Filed 2018·Granted May 16, 2023·0 cites·10 claims
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David Paschon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →